Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naomi Lomeli

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Bioorganic & Medicinal Chemistry Letters|May 18, 2023
Identification of new hit to lead magmas inhibitors as potential therapeutics for glioblastomaBhaskar C Das, Javier J Lepe, Mohammed Adil Shareef, et al.
Experimental Neurology|February 9, 2024
Cisplatin induces BDNF downregulation in middle-aged female rat model while BDNF enhancement attenuates cisplatin neurotoxicityNaomi Lomeli, Diana C Pearre, Maureen Cruz, et al.
Journal of Adolescent and Young Adult Oncology|October 21, 2021
Feasibility of Cognitive Training to Promote Recovery in Cancer-Related Cognitive Impairment in Adolescent and Young Adult PatientsMegan Gooch, Aditi Mehta, Tami John, et al.
Cancer Letters|December 20, 2024
N-acetylcysteine prevents cisplatin-induced cognitive impairments in an ovarian cancer rat modelNaomi Lomeli, Diana C Pearre, Javier Lepe, et al.
Cells|June 11, 2026
Simplified Procedure for Isolation and Culture of Neuronal Cells from Brains of Sickle Cell MiceYugal Goel, Mya A Arellano, Kendall O'Daniel, et al.
Cancer Research Communications|May 6, 2026
MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma ModelsJavier J Lepe, Jennifer D Tran, Naomi Lomeli, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
WITHDRAWN: Dual targeting of mitochondrial Lon peptidase 1 and chymotrypsin-like protease by small molecule BT317, as potential therapeutics in malignant astrocytomasChristopher Douglas, Shashi Jain, Naomi Lomeli, et al.
Pharmacological Research|March 15, 2025
Dual targeting of the mitochondrial Lon peptidase 1 and the chymotrypsin-like proteasome activity as a potential therapeutic strategy in malignant astrocytoma modelsChristopher Douglas, Shashi Jain, Naomi Lomeli, et al.
Frontiers in Oncology|July 15, 2022
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and TemozolomideDaniela A Bota, Thomas H Taylor, Naomi Lomeli, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Bioorganic & Medicinal Chemistry Letters|May 18, 2023
Identification of new hit to lead magmas inhibitors as potential therapeutics for glioblastomaBhaskar C Das, Javier J Lepe, Mohammed Adil Shareef, et al.
Experimental Neurology|February 9, 2024
Cisplatin induces BDNF downregulation in middle-aged female rat model while BDNF enhancement attenuates cisplatin neurotoxicityNaomi Lomeli, Diana C Pearre, Maureen Cruz, et al.
Journal of Adolescent and Young Adult Oncology|October 21, 2021
Feasibility of Cognitive Training to Promote Recovery in Cancer-Related Cognitive Impairment in Adolescent and Young Adult PatientsMegan Gooch, Aditi Mehta, Tami John, et al.
Cancer Letters|December 20, 2024
N-acetylcysteine prevents cisplatin-induced cognitive impairments in an ovarian cancer rat modelNaomi Lomeli, Diana C Pearre, Javier Lepe, et al.
Cells|June 11, 2026
Simplified Procedure for Isolation and Culture of Neuronal Cells from Brains of Sickle Cell MiceYugal Goel, Mya A Arellano, Kendall O'Daniel, et al.
Cancer Research Communications|May 6, 2026
MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma ModelsJavier J Lepe, Jennifer D Tran, Naomi Lomeli, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
WITHDRAWN: Dual targeting of mitochondrial Lon peptidase 1 and chymotrypsin-like protease by small molecule BT317, as potential therapeutics in malignant astrocytomasChristopher Douglas, Shashi Jain, Naomi Lomeli, et al.
Pharmacological Research|March 15, 2025
Dual targeting of the mitochondrial Lon peptidase 1 and the chymotrypsin-like proteasome activity as a potential therapeutic strategy in malignant astrocytoma modelsChristopher Douglas, Shashi Jain, Naomi Lomeli, et al.
Frontiers in Oncology|July 15, 2022
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and TemozolomideDaniela A Bota, Thomas H Taylor, Naomi Lomeli, et al.
Pageof 2